CardioLogs ECG Analysis Platform vs SignalHF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Implicity

AI Verdict

Tool A specializes in the AI-powered analysis of ECG data for the detection and diagnosis of various arrhythmias, aiding physicians in diagnostic workflows. In contrast, Tool B focuses on predicting heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices, enabling proactive intervention. While both are cardiology AI solutions, they address distinct clinical problems and utilize different data types.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid and accurate AI-powered analysis of diverse ECG data sources, including Holters, smartwatches, and patches, to detect and diagnose various arrhythmias. This platform is ideal for clinicians requiring efficient processing of large volumes of ECGs to streamline arrhythmia management and diagnosis across different monitoring devices.

View CardioLogs ECG Analysis Platform →

Choose SignalHF if…

Choose SignalHF by Implicity if your objective is to proactively predict and prevent heart failure hospitalizations within 30 days by leveraging AI analysis of cardiac implantable electronic device (CIED) data. This tool is best suited for cardiology teams managing patients with pacemakers, ICDs, or CRTs, who aim to identify high-risk individuals for early intervention and personalized care plans.

View SignalHF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform SignalHF
Pricing Unknown Contact for pricing
Deployment Cloud-based SaaS
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform SignalHF
Name CardioLogs ECG Analysis Platform SignalHF
Company Cardiologs Technologies (now part of Philips) Implicity
Primary Function/Focus Rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices.
Key AI Capability AI-Powered ECG Analysis (Deep Neural Networks) for automated arrhythmia detection. FDA-cleared AI algorithm for heart failure prediction based on CIED data.
Device Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs)
Target Outcome Aiding physicians in arrhythmia detection and diagnosis. Enables early intervention and personalized care plans to prevent heart failure hospitalizations.

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and SignalHF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform focuses on rapid, accurate, and efficient analysis of ECG data for arrhythmia detection and diagnosis. SignalHF by Implicity is designed to predict heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices.
CardioLogs ECG Analysis Platform analyzes ECG data from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. SignalHF by Implicity analyzes data from various cardiac implantable electronic devices (CIEDs) such as pacemakers, ICDs, and CRTs.
CardioLogs uses medical-grade AI (Deep Neural Networks) for automated arrhythmia detection and provides customizable reports to aid in diagnosis. SignalHF employs an FDA-cleared AI algorithm to predict heart failure hospitalizations and generates automatic alerts for care teams based on risk scores, enabling early intervention.
CardioLogs ECG Analysis Platform is relevant for Cardiology, Emergency Medicine, and Internal Medicine. SignalHF by Implicity is primarily targeted towards Cardiology specialists.
CardioLogs ECG Analysis Platform explicitly offers integration with EHR systems. SignalHF provides a unified platform for centralizing cardiac implantable device data and includes AI-driven alert management to filter and highlight relevant events.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.